To evaluate the prevalence of key infections (HIV, TB, and viral hepatitis) among migrants to the UK and explore prevalence stratified by risk factors for effective health planning and targeted testing strategies.
Key Findings:
Migrants to the UK have a higher prevalence of TB, HIV, and hepatitis B and C compared to native populations, with specific statistics indicating that in 2024, 82% of TB notifications were in individuals born outside the UK.
95% of new chronic hepatitis B diagnoses were in migrants, highlighting the significant health impact on this population.
Migrants often present later with infections and may experience more aggressive disease progression, necessitating timely interventions.
Interpretation:
The findings highlight the urgent need for targeted screening and management strategies for infectious diseases among migrant populations to improve health outcomes and reduce transmission.
Limitations:
Potential bias in study selection and reporting may affect the reliability of the findings.
Exclusion of certain study types may limit comprehensive understanding of the prevalence and impact of these infections.
Conclusion:
Effective health planning and targeted interventions are essential to address the increased risk of infectious diseases among migrants in the UK, emphasizing the need for immediate action.
Data suggest fewer respiratory syncytial virus–associated hospitalizations and emergency department visits among the youngest infants during the second season of routine prevention product use.
